Author:
Widayati Puji,Setiyowati Sri,Asyikin Khoirunnisa Fauziah,Ariyanto Agus,Lestari Wening,Fikri Ahsanal,Juliyanto Sumandi,Susilo Veronika Yulianti,Sulaiman Sulaiman,Ritawidya Rien
Reference21 articles.
1. 153 Sm-EDTMP for bone pain palliation in skeletal metastases
2. Bahrami-Samani A, Anvari A, Jalilian A.R., Shirvani-Arani S, Yousefnia H, Aghamiri M.R., et al. Production, quality control and pharmacokinetic studies of 177Lu-EDTMP for human bone pain palliation therapy trials. Iran J Pharm Res. 2012;11(1):137–44.
3. Ranjbar H, Bahrami-Samani A, Beiki D, Ghannadi-Maragheh M. Development of 153Sm / 177Lu-EDTMPas a possible therapeutic complex. Iran J Nucl Med. 2017;25(1):11–6.
4. Ja C, Rayne R. The management of intractable bone pain: A clinician’s perspective, Semin. Nucl. Med.(1992) 22: 3–10. Semin Nucl Med. 1992;22:3–10.
5. Das T, Sarma H.D., Shinto A, Kamaleshwaran K.K., Banerjee S. Formulation, preclinical evaluation, and preliminary clinical investigation of an in-house freeze-dried EDTMP kit suitable for the preparation of177Lu-EDTMP. Cancer Biother Radiopharm. 2014;29(10):412–21.